PCV29 ESTIMATING THE BUDGET IMPACT OF DABIGATRAN ETEXILATE IN THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWINGTOTAL HIP OR KNEE REPLACEMENT SURGERY- AN INTERACTIVE MODEL FOR LOCAL HEALTH ECONOMIES IN THE UK

Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66327-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)66327-9/fulltext
Title : PCV29 ESTIMATING THE BUDGET IMPACT OF DABIGATRAN ETEXILATE IN THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM FOLLOWINGTOTAL HIP OR KNEE REPLACEMENT SURGERY- AN INTERACTIVE MODEL FOR LOCAL HEALTH ECONOMIES IN THE UK
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66327-9&doi=10.1016/S1098-3015(10)66327-9
First page :
Section Title :
Open access? : No
Section Order : 162
Categories :
Tags :
Regions :
ViH Article Tags :